nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLC22A1—Progesterone—uterine cancer	0.0974	0.12	CbGbCtD
Nelfinavir—ABCG2—Dactinomycin—uterine cancer	0.0656	0.081	CbGbCtD
Nelfinavir—CYP3A7—Progesterone—uterine cancer	0.0611	0.0754	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0611	0.0754	CbGbCtD
Nelfinavir—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0464	0.0573	CbGbCtD
Nelfinavir—CYP3A5—Progesterone—uterine cancer	0.0458	0.0566	CbGbCtD
Nelfinavir—ABCG2—Carboplatin—uterine cancer	0.0441	0.0544	CbGbCtD
Nelfinavir—ABCG2—Etoposide—uterine cancer	0.037	0.0457	CbGbCtD
Nelfinavir—CYP2C19—Progesterone—uterine cancer	0.037	0.0456	CbGbCtD
Nelfinavir—CYP1A2—Progesterone—uterine cancer	0.0341	0.0421	CbGbCtD
Nelfinavir—CYP2C9—Progesterone—uterine cancer	0.0307	0.0379	CbGbCtD
Nelfinavir—ABCB1—Progesterone—uterine cancer	0.0298	0.0368	CbGbCtD
Nelfinavir—CYP2D6—Progesterone—uterine cancer	0.0281	0.0347	CbGbCtD
Nelfinavir—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.027	0.0333	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—uterine cancer	0.0253	0.0312	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—uterine cancer	0.0237	0.0292	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—uterine cancer	0.0205	0.0253	CbGbCtD
Nelfinavir—CYP3A4—Progesterone—uterine cancer	0.0179	0.0221	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—uterine cancer	0.0178	0.0219	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—uterine cancer	0.0153	0.0188	CbGbCtD
Nelfinavir—ABCB1—Etoposide—uterine cancer	0.0134	0.0165	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—uterine cancer	0.00911	0.0112	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—uterine cancer	0.00858	0.0106	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—uterine cancer	0.008	0.00987	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—uterine cancer	0.00546	0.00673	CbGbCtD
Nelfinavir—Saquinavir—CYP11A1—uterine cancer	0.00329	1	CrCbGaD
Nelfinavir—Jaundice—Etoposide—uterine cancer	0.000413	0.00235	CcSEcCtD
Nelfinavir—Stomatitis—Etoposide—uterine cancer	0.000413	0.00235	CcSEcCtD
Nelfinavir—Malaise—Dactinomycin—uterine cancer	0.000412	0.00235	CcSEcCtD
Nelfinavir—Leukopenia—Dactinomycin—uterine cancer	0.000409	0.00233	CcSEcCtD
Nelfinavir—Inflammation—Doxorubicin—uterine cancer	0.000405	0.00231	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Etoposide—uterine cancer	0.000401	0.00228	CcSEcCtD
Nelfinavir—Blood uric acid increased—Doxorubicin—uterine cancer	0.0004	0.00228	CcSEcCtD
Nelfinavir—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000394	0.00225	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000391	0.00223	CcSEcCtD
Nelfinavir—Myalgia—Dactinomycin—uterine cancer	0.000389	0.00222	CcSEcCtD
Nelfinavir—Hypersensitivity—Progesterone—uterine cancer	0.000389	0.00222	CcSEcCtD
Nelfinavir—Rash maculo-papular—Epirubicin—uterine cancer	0.000386	0.0022	CcSEcCtD
Nelfinavir—Discomfort—Dactinomycin—uterine cancer	0.000385	0.00219	CcSEcCtD
Nelfinavir—Mouth ulceration—Epirubicin—uterine cancer	0.000384	0.00219	CcSEcCtD
Nelfinavir—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00217	CcSEcCtD
Nelfinavir—Asthenia—Progesterone—uterine cancer	0.000379	0.00216	CcSEcCtD
Nelfinavir—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.00216	CcSEcCtD
Nelfinavir—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.00216	CcSEcCtD
Nelfinavir—Pruritus—Progesterone—uterine cancer	0.000374	0.00213	CcSEcCtD
Nelfinavir—Oedema—Dactinomycin—uterine cancer	0.000373	0.00213	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dactinomycin—uterine cancer	0.000365	0.00208	CcSEcCtD
Nelfinavir—Diarrhoea—Progesterone—uterine cancer	0.000361	0.00206	CcSEcCtD
Nelfinavir—Erythema multiforme—Etoposide—uterine cancer	0.00036	0.00205	CcSEcCtD
Nelfinavir—Rash maculo-papular—Doxorubicin—uterine cancer	0.000357	0.00204	CcSEcCtD
Nelfinavir—Anorexia—Dactinomycin—uterine cancer	0.000356	0.00203	CcSEcCtD
Nelfinavir—Eye disorder—Etoposide—uterine cancer	0.000355	0.00203	CcSEcCtD
Nelfinavir—Mouth ulceration—Doxorubicin—uterine cancer	0.000355	0.00203	CcSEcCtD
Nelfinavir—Diabetes mellitus—Epirubicin—uterine cancer	0.000354	0.00202	CcSEcCtD
Nelfinavir—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00201	CcSEcCtD
Nelfinavir—Dizziness—Progesterone—uterine cancer	0.000349	0.00199	CcSEcCtD
Nelfinavir—Angiopathy—Etoposide—uterine cancer	0.000345	0.00197	CcSEcCtD
Nelfinavir—Immune system disorder—Etoposide—uterine cancer	0.000343	0.00196	CcSEcCtD
Nelfinavir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.00196	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00034	0.00194	CcSEcCtD
Nelfinavir—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.00193	CcSEcCtD
Nelfinavir—Vomiting—Progesterone—uterine cancer	0.000336	0.00191	CcSEcCtD
Nelfinavir—Rash—Progesterone—uterine cancer	0.000333	0.0019	CcSEcCtD
Nelfinavir—Dermatitis—Progesterone—uterine cancer	0.000333	0.0019	CcSEcCtD
Nelfinavir—Headache—Progesterone—uterine cancer	0.000331	0.00189	CcSEcCtD
Nelfinavir—Diabetes mellitus—Doxorubicin—uterine cancer	0.000328	0.00187	CcSEcCtD
Nelfinavir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.00187	CcSEcCtD
Nelfinavir—Decreased appetite—Dactinomycin—uterine cancer	0.000324	0.00185	CcSEcCtD
Nelfinavir—Dermatitis bullous—Epirubicin—uterine cancer	0.000322	0.00184	CcSEcCtD
Nelfinavir—Back pain—Etoposide—uterine cancer	0.00032	0.00183	CcSEcCtD
Nelfinavir—Pain—Dactinomycin—uterine cancer	0.000319	0.00182	CcSEcCtD
Nelfinavir—Muscle spasms—Etoposide—uterine cancer	0.000318	0.00181	CcSEcCtD
Nelfinavir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000316	0.0018	CcSEcCtD
Nelfinavir—Hypoglycaemia—Epirubicin—uterine cancer	0.000316	0.0018	CcSEcCtD
Nelfinavir—Nausea—Progesterone—uterine cancer	0.000314	0.00179	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000308	0.00176	CcSEcCtD
Nelfinavir—Feeling abnormal—Dactinomycin—uterine cancer	0.000308	0.00175	CcSEcCtD
Nelfinavir—Ill-defined disorder—Etoposide—uterine cancer	0.000307	0.00175	CcSEcCtD
Nelfinavir—Anaemia—Etoposide—uterine cancer	0.000306	0.00174	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000305	0.00174	CcSEcCtD
Nelfinavir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000304	0.00174	CcSEcCtD
Nelfinavir—Migraine—Epirubicin—uterine cancer	0.000303	0.00173	CcSEcCtD
Nelfinavir—Affect lability—Epirubicin—uterine cancer	0.000303	0.00173	CcSEcCtD
Nelfinavir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00172	CcSEcCtD
Nelfinavir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000301	0.00172	CcSEcCtD
Nelfinavir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.00171	CcSEcCtD
Nelfinavir—Malaise—Etoposide—uterine cancer	0.000298	0.0017	CcSEcCtD
Nelfinavir—Dermatitis bullous—Doxorubicin—uterine cancer	0.000298	0.0017	CcSEcCtD
Nelfinavir—Leukopenia—Etoposide—uterine cancer	0.000296	0.00169	CcSEcCtD
Nelfinavir—Body temperature increased—Dactinomycin—uterine cancer	0.000295	0.00168	CcSEcCtD
Nelfinavir—Abdominal pain—Dactinomycin—uterine cancer	0.000295	0.00168	CcSEcCtD
Nelfinavir—Hypoglycaemia—Doxorubicin—uterine cancer	0.000292	0.00167	CcSEcCtD
Nelfinavir—Mood swings—Epirubicin—uterine cancer	0.000292	0.00166	CcSEcCtD
Nelfinavir—Convulsion—Etoposide—uterine cancer	0.000287	0.00164	CcSEcCtD
Nelfinavir—Dehydration—Epirubicin—uterine cancer	0.000287	0.00163	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000285	0.00163	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—uterine cancer	0.000284	0.00162	CcSEcCtD
Nelfinavir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.00162	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—uterine cancer	0.000281	0.0016	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—uterine cancer	0.000281	0.0016	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—uterine cancer	0.000281	0.0016	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00028	0.0016	CcSEcCtD
Nelfinavir—Discomfort—Etoposide—uterine cancer	0.000278	0.00159	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000277	0.00158	CcSEcCtD
Nelfinavir—Hypersensitivity—Dactinomycin—uterine cancer	0.000275	0.00157	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—uterine cancer	0.000272	0.00155	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000272	0.00155	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—uterine cancer	0.00027	0.00154	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—uterine cancer	0.000268	0.00153	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—uterine cancer	0.000268	0.00153	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—uterine cancer	0.000265	0.00151	CcSEcCtD
Nelfinavir—Thrombocytopenia—Etoposide—uterine cancer	0.000264	0.00151	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—uterine cancer	0.000263	0.0015	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—uterine cancer	0.000262	0.0015	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—uterine cancer	0.000261	0.00149	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—uterine cancer	0.000261	0.00149	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—uterine cancer	0.00026	0.00148	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—uterine cancer	0.000258	0.00147	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000257	0.00146	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—uterine cancer	0.000255	0.00146	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—uterine cancer	0.000251	0.00143	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000251	0.00143	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—uterine cancer	0.000249	0.00142	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—uterine cancer	0.000248	0.00141	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—uterine cancer	0.000243	0.00138	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—uterine cancer	0.000242	0.00138	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—uterine cancer	0.000241	0.00137	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—uterine cancer	0.00024	0.00137	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—uterine cancer	0.00024	0.00137	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—uterine cancer	0.000239	0.00136	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—uterine cancer	0.000237	0.00135	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—uterine cancer	0.000235	0.00134	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—uterine cancer	0.000235	0.00134	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000233	0.00133	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—uterine cancer	0.000231	0.00132	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—uterine cancer	0.000231	0.00132	CcSEcCtD
Nelfinavir—Pain—Etoposide—uterine cancer	0.000231	0.00132	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—uterine cancer	0.00023	0.00131	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—uterine cancer	0.000228	0.0013	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000225	0.00128	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—uterine cancer	0.000224	0.00128	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—uterine cancer	0.000223	0.00127	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—uterine cancer	0.000223	0.00127	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000222	0.00127	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—uterine cancer	0.000222	0.00126	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—uterine cancer	0.000221	0.00126	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—uterine cancer	0.000221	0.00126	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—uterine cancer	0.000215	0.00122	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—uterine cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—uterine cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—uterine cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—uterine cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—uterine cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—uterine cancer	0.000214	0.00122	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—uterine cancer	0.000213	0.00122	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—uterine cancer	0.000213	0.00122	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—uterine cancer	0.000212	0.00121	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—uterine cancer	0.000211	0.0012	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—uterine cancer	0.000209	0.00119	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000208	0.00118	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—uterine cancer	0.000207	0.00118	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—uterine cancer	0.000206	0.00118	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—uterine cancer	0.000202	0.00115	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—uterine cancer	0.000199	0.00114	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—uterine cancer	0.000199	0.00114	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—uterine cancer	0.000198	0.00113	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—uterine cancer	0.000198	0.00113	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—uterine cancer	0.000197	0.00112	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—uterine cancer	0.000197	0.00112	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—uterine cancer	0.000196	0.00112	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—uterine cancer	0.000194	0.00111	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000194	0.00111	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—uterine cancer	0.000193	0.0011	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—uterine cancer	0.000193	0.0011	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—uterine cancer	0.000191	0.00109	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—uterine cancer	0.000186	0.00106	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—uterine cancer	0.000186	0.00106	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—uterine cancer	0.000186	0.00106	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—uterine cancer	0.000185	0.00105	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—uterine cancer	0.000184	0.00105	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—uterine cancer	0.000183	0.00104	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—uterine cancer	0.000179	0.00102	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—uterine cancer	0.000179	0.00102	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—uterine cancer	0.000179	0.00102	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—uterine cancer	0.000178	0.00102	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—uterine cancer	0.000178	0.00102	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—uterine cancer	0.000172	0.000982	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—uterine cancer	0.000172	0.00098	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—uterine cancer	0.000172	0.000979	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—uterine cancer	0.000172	0.000979	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—uterine cancer	0.000171	0.000978	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—uterine cancer	0.000171	0.000972	CcSEcCtD
Nelfinavir—Rash—Etoposide—uterine cancer	0.00017	0.000971	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—uterine cancer	0.00017	0.000971	CcSEcCtD
Nelfinavir—Headache—Etoposide—uterine cancer	0.000169	0.000965	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—uterine cancer	0.000169	0.000965	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—uterine cancer	0.000167	0.000954	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—uterine cancer	0.000166	0.000947	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—uterine cancer	0.000166	0.000947	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—uterine cancer	0.000165	0.000941	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—uterine cancer	0.000161	0.000917	CcSEcCtD
Nelfinavir—Nausea—Etoposide—uterine cancer	0.00016	0.000915	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000159	0.000908	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—uterine cancer	0.000159	0.000905	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—uterine cancer	0.000158	0.000901	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—uterine cancer	0.000158	0.000901	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—uterine cancer	0.000158	0.0009	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—uterine cancer	0.000157	0.000898	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000157	0.000895	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—uterine cancer	0.000156	0.00089	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—uterine cancer	0.000155	0.000883	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—uterine cancer	0.000154	0.000876	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—uterine cancer	0.000151	0.000864	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—uterine cancer	0.000149	0.000848	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—uterine cancer	0.000148	0.000846	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—uterine cancer	0.000147	0.000839	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—uterine cancer	0.000146	0.000835	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—uterine cancer	0.000146	0.000834	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—uterine cancer	0.000146	0.000834	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—uterine cancer	0.000146	0.000831	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000145	0.000828	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—uterine cancer	0.000144	0.000824	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—uterine cancer	0.000144	0.000823	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—uterine cancer	0.00014	0.000799	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000138	0.000787	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000137	0.000782	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—uterine cancer	0.000137	0.000781	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—uterine cancer	0.000136	0.000776	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—uterine cancer	0.000136	0.000775	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—uterine cancer	0.000135	0.000773	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—uterine cancer	0.000135	0.00077	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—uterine cancer	0.000135	0.000768	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—uterine cancer	0.000134	0.000762	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—uterine cancer	0.000133	0.00076	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—uterine cancer	0.000132	0.000751	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000131	0.000746	CcSEcCtD
Nelfinavir—Pain—Epirubicin—uterine cancer	0.000129	0.000739	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000128	0.000728	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—uterine cancer	0.000127	0.000723	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—uterine cancer	0.000126	0.000718	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—uterine cancer	0.000125	0.000712	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—uterine cancer	0.000125	0.000712	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—uterine cancer	0.000125	0.00071	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000124	0.000706	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—uterine cancer	0.000123	0.000703	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—uterine cancer	0.000122	0.000695	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000121	0.00069	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—uterine cancer	0.00012	0.000686	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—uterine cancer	0.00012	0.000683	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—uterine cancer	0.00012	0.000683	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—uterine cancer	0.00012	0.000683	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—uterine cancer	0.000115	0.000658	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000115	0.000653	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—uterine cancer	0.000112	0.000636	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—uterine cancer	0.000111	0.000635	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—uterine cancer	0.000111	0.000632	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—uterine cancer	0.000111	0.000632	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—uterine cancer	0.000109	0.00062	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—uterine cancer	0.000107	0.000611	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—uterine cancer	0.000104	0.000591	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—uterine cancer	0.000103	0.000589	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—uterine cancer	0.000101	0.000573	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—uterine cancer	0.0001	0.000571	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—uterine cancer	9.91e-05	0.000565	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—uterine cancer	9.63e-05	0.000549	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—uterine cancer	9.59e-05	0.000547	CcSEcCtD
Nelfinavir—Rash—Epirubicin—uterine cancer	9.55e-05	0.000545	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—uterine cancer	9.54e-05	0.000544	CcSEcCtD
Nelfinavir—Headache—Epirubicin—uterine cancer	9.49e-05	0.000541	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—uterine cancer	9.27e-05	0.000528	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—uterine cancer	8.99e-05	0.000513	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—uterine cancer	8.91e-05	0.000508	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—uterine cancer	8.83e-05	0.000504	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—uterine cancer	8.83e-05	0.000503	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—uterine cancer	8.78e-05	0.000501	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—uterine cancer	8.32e-05	0.000475	CcSEcCtD
Nelfinavir—SLCO1B1—renal system—uterine cancer	4.54e-05	0.0563	CbGeAlD
Nelfinavir—SLC22A1—renal system—uterine cancer	3.84e-05	0.0476	CbGeAlD
Nelfinavir—SLCO1A2—renal system—uterine cancer	3.69e-05	0.0458	CbGeAlD
Nelfinavir—SLCO1B1—female reproductive system—uterine cancer	3.63e-05	0.0451	CbGeAlD
Nelfinavir—ABCG2—myometrium—uterine cancer	3.45e-05	0.0428	CbGeAlD
Nelfinavir—SLC22A1—vagina—uterine cancer	2.78e-05	0.0345	CbGeAlD
Nelfinavir—ABCG2—uterine cervix—uterine cancer	2.68e-05	0.0333	CbGeAlD
Nelfinavir—ABCG2—decidua—uterine cancer	2.56e-05	0.0317	CbGeAlD
Nelfinavir—CYP3A5—uterine cervix—uterine cancer	2.49e-05	0.0309	CbGeAlD
Nelfinavir—ABCG2—endometrium—uterine cancer	2.43e-05	0.0301	CbGeAlD
Nelfinavir—CYP1A2—renal system—uterine cancer	2.41e-05	0.03	CbGeAlD
Nelfinavir—ABCG2—mammalian vulva—uterine cancer	2.35e-05	0.0291	CbGeAlD
Nelfinavir—CYP3A5—renal system—uterine cancer	2.33e-05	0.0289	CbGeAlD
Nelfinavir—CYP2B6—renal system—uterine cancer	2.31e-05	0.0287	CbGeAlD
Nelfinavir—ABCG2—uterus—uterine cancer	2.24e-05	0.0277	CbGeAlD
Nelfinavir—CYP2C19—vagina—uterine cancer	2.14e-05	0.0266	CbGeAlD
Nelfinavir—CYP2B6—female reproductive system—uterine cancer	1.85e-05	0.023	CbGeAlD
Nelfinavir—CYP2C9—female reproductive system—uterine cancer	1.84e-05	0.0228	CbGeAlD
Nelfinavir—ABCG2—female gonad—uterine cancer	1.83e-05	0.0227	CbGeAlD
Nelfinavir—ABCG2—vagina—uterine cancer	1.82e-05	0.0225	CbGeAlD
Nelfinavir—CYP3A4—renal system—uterine cancer	1.75e-05	0.0217	CbGeAlD
Nelfinavir—CYP2D6—renal system—uterine cancer	1.72e-05	0.0213	CbGeAlD
Nelfinavir—ABCB1—myometrium—uterine cancer	1.7e-05	0.0211	CbGeAlD
Nelfinavir—CYP3A5—female gonad—uterine cancer	1.7e-05	0.0211	CbGeAlD
Nelfinavir—CYP3A5—vagina—uterine cancer	1.69e-05	0.0209	CbGeAlD
Nelfinavir—CYP2B6—vagina—uterine cancer	1.68e-05	0.0208	CbGeAlD
Nelfinavir—CYP3A4—female reproductive system—uterine cancer	1.4e-05	0.0174	CbGeAlD
Nelfinavir—CYP2D6—female reproductive system—uterine cancer	1.38e-05	0.0171	CbGeAlD
Nelfinavir—CYP3A7—Metabolism—STAR—uterine cancer	1.35e-05	0.00133	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.35e-05	0.00133	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—POLD1—uterine cancer	1.35e-05	0.00133	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.35e-05	0.00133	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.35e-05	0.00133	CbGpPWpGaD
Nelfinavir—ABCB1—epithelium—uterine cancer	1.33e-05	0.0165	CbGeAlD
Nelfinavir—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.33e-05	0.00132	CbGpPWpGaD
Nelfinavir—ABCB1—uterine cervix—uterine cancer	1.32e-05	0.0164	CbGeAlD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.32e-05	0.0013	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.32e-05	0.0013	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.00125	CbGpPWpGaD
Nelfinavir—ABCB1—decidua—uterine cancer	1.26e-05	0.0156	CbGeAlD
Nelfinavir—SLC22A1—Metabolism—STAR—uterine cancer	1.25e-05	0.00124	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKR1B1—uterine cancer	1.25e-05	0.00124	CbGpPWpGaD
Nelfinavir—CYP2D6—female gonad—uterine cancer	1.25e-05	0.0156	CbGeAlD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.24e-05	0.00123	CbGpPWpGaD
Nelfinavir—ABCB1—renal system—uterine cancer	1.24e-05	0.0154	CbGeAlD
Nelfinavir—ABCB1—endometrium—uterine cancer	1.2e-05	0.0148	CbGeAlD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.18e-05	0.00117	CbGpPWpGaD
Nelfinavir—ABCG2—lymph node—uterine cancer	1.18e-05	0.0146	CbGeAlD
Nelfinavir—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.17e-05	0.00115	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.16e-05	0.00115	CbGpPWpGaD
Nelfinavir—ABCB1—mammalian vulva—uterine cancer	1.16e-05	0.0144	CbGeAlD
Nelfinavir—SLCO1B1—Metabolism—POLD1—uterine cancer	1.15e-05	0.00114	CbGpPWpGaD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.15e-05	0.00114	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.13e-05	0.00112	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—RRM2—uterine cancer	1.12e-05	0.00111	CbGpPWpGaD
Nelfinavir—ABCB1—uterus—uterine cancer	1.1e-05	0.0137	CbGeAlD
Nelfinavir—SLCO1A2—Metabolism—DCN—uterine cancer	1.09e-05	0.00108	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKR1C1—uterine cancer	1.08e-05	0.00106	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—POLD1—uterine cancer	1.07e-05	0.00105	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—POLD1—uterine cancer	1.06e-05	0.00104	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.04e-05	0.00103	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.04e-05	0.00103	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.00102	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NDUFB11—uterine cancer	1.02e-05	0.001	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—SRD5A2—uterine cancer	1.02e-05	0.001	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.01e-05	0.001	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKR1C1—uterine cancer	9.99e-06	0.000986	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—STAR—uterine cancer	9.97e-06	0.000985	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKR1B1—uterine cancer	9.97e-06	0.000985	CbGpPWpGaD
Nelfinavir—ABCB1—female reproductive system—uterine cancer	9.91e-06	0.0123	CbGeAlD
Nelfinavir—CYP3A7—Metabolism—AKR1C1—uterine cancer	9.9e-06	0.000977	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—POLD1—uterine cancer	9.85e-06	0.000972	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	9.82e-06	0.000969	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—STAR—uterine cancer	9.75e-06	0.000963	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKR1B1—uterine cancer	9.75e-06	0.000963	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKR1C3—uterine cancer	9.71e-06	0.000959	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.68e-06	0.000956	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—RRM2—uterine cancer	9.61e-06	0.000949	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—SRD5A2—uterine cancer	9.59e-06	0.000947	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NDUFB11—uterine cancer	9.59e-06	0.000947	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.56e-06	0.000944	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NDUFB11—uterine cancer	9.5e-06	0.000939	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—SRD5A2—uterine cancer	9.5e-06	0.000939	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—DCN—uterine cancer	9.33e-06	0.000921	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.23e-06	0.000912	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKR1C1—uterine cancer	9.21e-06	0.00091	CbGpPWpGaD
Nelfinavir—ABCB1—female gonad—uterine cancer	9.02e-06	0.0112	CbGeAlD
Nelfinavir—ABCB1—vagina—uterine cancer	8.96e-06	0.0111	CbGeAlD
Nelfinavir—ABCG2—Metabolism—RRM2—uterine cancer	8.9e-06	0.000879	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—RRM2—uterine cancer	8.82e-06	0.000871	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP11A1—uterine cancer	8.79e-06	0.000868	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.72e-06	0.000861	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—DCN—uterine cancer	8.64e-06	0.000853	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—DCN—uterine cancer	8.56e-06	0.000846	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	8.54e-06	0.000843	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKR1C3—uterine cancer	8.3e-06	0.00082	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—RRM2—uterine cancer	8.21e-06	0.000811	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP11A1—uterine cancer	8.14e-06	0.000804	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—SRD5A2—uterine cancer	8.12e-06	0.000802	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NDUFB11—uterine cancer	8.12e-06	0.000802	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP11A1—uterine cancer	8.07e-06	0.000797	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—DCN—uterine cancer	7.97e-06	0.000787	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	7.9e-06	0.000781	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.89e-06	0.000779	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—POLD1—uterine cancer	7.83e-06	0.000773	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	7.81e-06	0.000771	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKR1C3—uterine cancer	7.69e-06	0.000759	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—POLD1—uterine cancer	7.65e-06	0.000755	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKR1C3—uterine cancer	7.62e-06	0.000752	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP19A1—uterine cancer	7.56e-06	0.000747	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—STK11—uterine cancer	7.56e-06	0.000747	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKR1B1—uterine cancer	7.54e-06	0.000744	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—STAR—uterine cancer	7.54e-06	0.000744	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP11A1—uterine cancer	7.51e-06	0.000741	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	7.47e-06	0.000737	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.45e-06	0.000736	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.45e-06	0.000736	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKR1B1—uterine cancer	7.36e-06	0.000726	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—STAR—uterine cancer	7.36e-06	0.000726	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKR1C1—uterine cancer	7.32e-06	0.000723	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	7.28e-06	0.000719	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKR1C1—uterine cancer	7.15e-06	0.000707	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.1e-06	0.000701	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKR1C3—uterine cancer	7.09e-06	0.0007	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	6.94e-06	0.000685	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—STAR—uterine cancer	6.93e-06	0.000684	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKR1B1—uterine cancer	6.93e-06	0.000684	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKR1B1—uterine cancer	6.87e-06	0.000679	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—STAR—uterine cancer	6.87e-06	0.000679	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.79e-06	0.000671	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.77e-06	0.000669	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	6.57e-06	0.000649	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—RRM2—uterine cancer	6.52e-06	0.000644	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—STK11—uterine cancer	6.47e-06	0.000639	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP19A1—uterine cancer	6.47e-06	0.000639	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—RRM2—uterine cancer	6.38e-06	0.00063	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—DCN—uterine cancer	6.33e-06	0.000625	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.27e-06	0.000619	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.27e-06	0.000619	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—DCN—uterine cancer	6.19e-06	0.000611	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.07e-06	0.0006	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—STK11—uterine cancer	5.99e-06	0.000591	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP19A1—uterine cancer	5.99e-06	0.000591	CbGpPWpGaD
Nelfinavir—SLC22A1—Neuronal System—HRAS—uterine cancer	5.99e-06	0.000591	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP11A1—uterine cancer	5.97e-06	0.000589	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP19A1—uterine cancer	5.94e-06	0.000586	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—STK11—uterine cancer	5.94e-06	0.000586	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—POLD1—uterine cancer	5.91e-06	0.000584	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKR1B1—uterine cancer	5.87e-06	0.00058	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—STAR—uterine cancer	5.87e-06	0.00058	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP11A1—uterine cancer	5.83e-06	0.000576	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.8e-06	0.000573	CbGpPWpGaD
Nelfinavir—ABCB1—lymph node—uterine cancer	5.8e-06	0.00719	CbGeAlD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.79e-06	0.000572	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—POLD1—uterine cancer	5.77e-06	0.00057	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—MTHFR—uterine cancer	5.68e-06	0.000561	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKR1C3—uterine cancer	5.64e-06	0.000556	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.59e-06	0.000552	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKR1C1—uterine cancer	5.53e-06	0.000546	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP19A1—uterine cancer	5.52e-06	0.000546	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—STK11—uterine cancer	5.52e-06	0.000546	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKR1C3—uterine cancer	5.51e-06	0.000544	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—POLD1—uterine cancer	5.44e-06	0.000537	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKR1C1—uterine cancer	5.4e-06	0.000533	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—POLD1—uterine cancer	5.39e-06	0.000532	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.13e-06	0.000507	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKR1C1—uterine cancer	5.09e-06	0.000502	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKR1C1—uterine cancer	5.04e-06	0.000498	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.01e-06	0.000495	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.97e-06	0.000491	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—RRM2—uterine cancer	4.93e-06	0.000487	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—MTHFR—uterine cancer	4.86e-06	0.00048	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—RRM2—uterine cancer	4.81e-06	0.000475	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—DCN—uterine cancer	4.79e-06	0.000473	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—DCN—uterine cancer	4.67e-06	0.000461	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—POLD1—uterine cancer	4.61e-06	0.000455	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—RRM2—uterine cancer	4.53e-06	0.000448	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—STAR—uterine cancer	4.53e-06	0.000448	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.53e-06	0.000448	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP11A1—uterine cancer	4.51e-06	0.000445	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—MTHFR—uterine cancer	4.5e-06	0.000444	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—RRM2—uterine cancer	4.5e-06	0.000444	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—MTHFR—uterine cancer	4.46e-06	0.000441	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—DCN—uterine cancer	4.4e-06	0.000435	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP11A1—uterine cancer	4.4e-06	0.000435	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP19A1—uterine cancer	4.39e-06	0.000434	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—STK11—uterine cancer	4.39e-06	0.000434	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—DCN—uterine cancer	4.36e-06	0.000431	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKR1C1—uterine cancer	4.31e-06	0.000426	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—STK11—uterine cancer	4.29e-06	0.000424	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP19A1—uterine cancer	4.29e-06	0.000424	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.28e-06	0.000423	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKR1C3—uterine cancer	4.26e-06	0.000421	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.19e-06	0.000414	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKR1C3—uterine cancer	4.16e-06	0.00041	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—MTHFR—uterine cancer	4.15e-06	0.00041	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP11A1—uterine cancer	4.15e-06	0.00041	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP11A1—uterine cancer	4.11e-06	0.000406	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKR1C3—uterine cancer	3.92e-06	0.000387	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKR1C3—uterine cancer	3.88e-06	0.000383	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—RRM2—uterine cancer	3.84e-06	0.000379	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—DCN—uterine cancer	3.73e-06	0.000368	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—POLD1—uterine cancer	3.56e-06	0.000351	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP11A1—uterine cancer	3.51e-06	0.000347	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.33e-06	0.000328	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKR1C3—uterine cancer	3.32e-06	0.000328	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—STK11—uterine cancer	3.32e-06	0.000328	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP19A1—uterine cancer	3.32e-06	0.000328	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—MTHFR—uterine cancer	3.3e-06	0.000326	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP19A1—uterine cancer	3.24e-06	0.00032	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—STK11—uterine cancer	3.24e-06	0.00032	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—MTHFR—uterine cancer	3.22e-06	0.000318	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—uterine cancer	3.16e-06	0.000312	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.11e-06	0.000308	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP19A1—uterine cancer	3.05e-06	0.000301	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—STK11—uterine cancer	3.05e-06	0.000301	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.02e-06	0.000299	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—STK11—uterine cancer	3.02e-06	0.000299	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—EP300—uterine cancer	3.02e-06	0.000298	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.97e-06	0.000293	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—RRM2—uterine cancer	2.96e-06	0.000293	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—DCN—uterine cancer	2.88e-06	0.000284	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.84e-06	0.00028	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.71e-06	0.000268	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.71e-06	0.000267	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—uterine cancer	2.7e-06	0.000267	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP19A1—uterine cancer	2.58e-06	0.000255	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—STK11—uterine cancer	2.58e-06	0.000255	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—EP300—uterine cancer	2.58e-06	0.000255	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.56e-06	0.000253	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—uterine cancer	2.5e-06	0.000247	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—MTHFR—uterine cancer	2.49e-06	0.000246	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—uterine cancer	2.48e-06	0.000245	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—MTHFR—uterine cancer	2.43e-06	0.00024	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.43e-06	0.00024	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—EP300—uterine cancer	2.39e-06	0.000236	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—EP300—uterine cancer	2.37e-06	0.000234	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.31e-06	0.000229	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—uterine cancer	2.31e-06	0.000228	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—MTHFR—uterine cancer	2.29e-06	0.000226	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—MTHFR—uterine cancer	2.27e-06	0.000224	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—uterine cancer	2.23e-06	0.00022	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—EP300—uterine cancer	2.2e-06	0.000217	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.2e-06	0.000217	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2e-06	0.000198	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—STK11—uterine cancer	1.99e-06	0.000197	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.99e-06	0.000197	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—MTHFR—uterine cancer	1.94e-06	0.000192	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—uterine cancer	1.91e-06	0.000188	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—uterine cancer	1.84e-06	0.000181	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—uterine cancer	1.82e-06	0.00018	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—uterine cancer	1.79e-06	0.000177	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—uterine cancer	1.77e-06	0.000174	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.75e-06	0.000173	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—EP300—uterine cancer	1.75e-06	0.000173	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.71e-06	0.000169	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—EP300—uterine cancer	1.71e-06	0.000169	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—uterine cancer	1.63e-06	0.000161	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—uterine cancer	1.56e-06	0.000154	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—MTHFR—uterine cancer	1.5e-06	0.000148	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—uterine cancer	1.44e-06	0.000142	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—uterine cancer	1.43e-06	0.000141	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—uterine cancer	1.39e-06	0.000137	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—uterine cancer	1.35e-06	0.000134	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—uterine cancer	1.33e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—EP300—uterine cancer	1.32e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.29e-06	0.000128	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—EP300—uterine cancer	1.29e-06	0.000127	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—uterine cancer	1.28e-06	0.000126	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.27e-06	0.000125	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—uterine cancer	1.26e-06	0.000125	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—EP300—uterine cancer	1.22e-06	0.00012	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—EP300—uterine cancer	1.21e-06	0.000119	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—uterine cancer	1.08e-06	0.000107	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—uterine cancer	1.06e-06	0.000104	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—uterine cancer	1.03e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—EP300—uterine cancer	1.03e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—uterine cancer	9.78e-07	9.66e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—uterine cancer	9.55e-07	9.43e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—uterine cancer	9e-07	8.89e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—uterine cancer	8.92e-07	8.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—uterine cancer	8.34e-07	8.24e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—uterine cancer	7.99e-07	7.89e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—EP300—uterine cancer	7.95e-07	7.85e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—uterine cancer	7.8e-07	7.7e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—uterine cancer	7.62e-07	7.53e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—uterine cancer	7.35e-07	7.26e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—uterine cancer	7.29e-07	7.2e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—uterine cancer	6.23e-07	6.15e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.88e-07	5.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—uterine cancer	4.81e-07	4.75e-05	CbGpPWpGaD
